Pelvic inflammatory disease: Improving awareness, prevention, and treatment

Breanne B. Das, Jocelyn Ronda, Maria E Trent

Research output: Contribution to journalReview article

Abstract

Purpose: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexually transmitted infections (STIs) and promptly treating individuals with STIs and PID. Recent findings: The rates of adverse outcomes in women with PID are high and disproportionately affect young minority women. There are key opportunities for prevention including improving provider adherence with national screening guidelines for STIs and PID treatment recommendations and patient medication adherence. Nearly half of all eligible women are not screened for STIs according to national quality standards, which may increase the risk of both acute and subclinical PID. Moreover, in clinical practice, providers poorly adhere to the Centers for Disease Control and Prevention recommendations for treatment of PID. Additionally, patients with PID struggle to adhere to the current management strategies in the outpatient setting. Conclusion: Novel evidence-based clinical and public health interventions to further reduce the rates of PID and to improve outcomes for affected women are warranted. We propose potential cost-effective approaches that could be employed in real-world settings.

Original languageEnglish (US)
Pages (from-to)191-197
Number of pages7
JournalInfection and Drug Resistance
Volume9
DOIs
StatePublished - Aug 19 2016

Fingerprint

Pelvic Inflammatory Disease
Sexually Transmitted Diseases
Therapeutics
Pelvic Pain
Medication Adherence
Ectopic Pregnancy
Centers for Disease Control and Prevention (U.S.)
Patient Compliance
Diagnostic Errors
Chronic Pain
Infertility
Outpatients
Public Health
Guidelines
Costs and Cost Analysis

Keywords

  • Disparities
  • Pelvic inflammatory disease
  • Treatment

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Pelvic inflammatory disease : Improving awareness, prevention, and treatment. / Das, Breanne B.; Ronda, Jocelyn; Trent, Maria E.

In: Infection and Drug Resistance, Vol. 9, 19.08.2016, p. 191-197.

Research output: Contribution to journalReview article

@article{f70216ca9fbb422881da65f6069ff3b2,
title = "Pelvic inflammatory disease: Improving awareness, prevention, and treatment",
abstract = "Purpose: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexually transmitted infections (STIs) and promptly treating individuals with STIs and PID. Recent findings: The rates of adverse outcomes in women with PID are high and disproportionately affect young minority women. There are key opportunities for prevention including improving provider adherence with national screening guidelines for STIs and PID treatment recommendations and patient medication adherence. Nearly half of all eligible women are not screened for STIs according to national quality standards, which may increase the risk of both acute and subclinical PID. Moreover, in clinical practice, providers poorly adhere to the Centers for Disease Control and Prevention recommendations for treatment of PID. Additionally, patients with PID struggle to adhere to the current management strategies in the outpatient setting. Conclusion: Novel evidence-based clinical and public health interventions to further reduce the rates of PID and to improve outcomes for affected women are warranted. We propose potential cost-effective approaches that could be employed in real-world settings.",
keywords = "Disparities, Pelvic inflammatory disease, Treatment",
author = "Das, {Breanne B.} and Jocelyn Ronda and Trent, {Maria E}",
year = "2016",
month = "8",
day = "19",
doi = "10.2147/IDR.S91260",
language = "English (US)",
volume = "9",
pages = "191--197",
journal = "Infection and Drug Resistance",
issn = "1178-6973",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Pelvic inflammatory disease

T2 - Improving awareness, prevention, and treatment

AU - Das, Breanne B.

AU - Ronda, Jocelyn

AU - Trent, Maria E

PY - 2016/8/19

Y1 - 2016/8/19

N2 - Purpose: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexually transmitted infections (STIs) and promptly treating individuals with STIs and PID. Recent findings: The rates of adverse outcomes in women with PID are high and disproportionately affect young minority women. There are key opportunities for prevention including improving provider adherence with national screening guidelines for STIs and PID treatment recommendations and patient medication adherence. Nearly half of all eligible women are not screened for STIs according to national quality standards, which may increase the risk of both acute and subclinical PID. Moreover, in clinical practice, providers poorly adhere to the Centers for Disease Control and Prevention recommendations for treatment of PID. Additionally, patients with PID struggle to adhere to the current management strategies in the outpatient setting. Conclusion: Novel evidence-based clinical and public health interventions to further reduce the rates of PID and to improve outcomes for affected women are warranted. We propose potential cost-effective approaches that could be employed in real-world settings.

AB - Purpose: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexually transmitted infections (STIs) and promptly treating individuals with STIs and PID. Recent findings: The rates of adverse outcomes in women with PID are high and disproportionately affect young minority women. There are key opportunities for prevention including improving provider adherence with national screening guidelines for STIs and PID treatment recommendations and patient medication adherence. Nearly half of all eligible women are not screened for STIs according to national quality standards, which may increase the risk of both acute and subclinical PID. Moreover, in clinical practice, providers poorly adhere to the Centers for Disease Control and Prevention recommendations for treatment of PID. Additionally, patients with PID struggle to adhere to the current management strategies in the outpatient setting. Conclusion: Novel evidence-based clinical and public health interventions to further reduce the rates of PID and to improve outcomes for affected women are warranted. We propose potential cost-effective approaches that could be employed in real-world settings.

KW - Disparities

KW - Pelvic inflammatory disease

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84989213426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989213426&partnerID=8YFLogxK

U2 - 10.2147/IDR.S91260

DO - 10.2147/IDR.S91260

M3 - Review article

C2 - 27578991

AN - SCOPUS:84989213426

VL - 9

SP - 191

EP - 197

JO - Infection and Drug Resistance

JF - Infection and Drug Resistance

SN - 1178-6973

ER -